4//SEC Filing
Hurley Ariel 4
Accession 0001415889-25-012248
CIK 0001597264other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 4:30 PM ET
Size
12.6 KB
Accession
0001415889-25-012248
Insider Transaction Report
Form 4
Hurley Ariel
PRINCIPAL ACCOUNTING OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-05-05$54.13/sh+2,752$148,966→ 19,696 total - Sale
Common Stock
2025-05-05$104.78/sh−100$10,478→ 16,944 total - Sale
Common Stock
2025-05-05$103.57/sh−1,400$144,998→ 17,044 total - Sale
Common Stock
2025-05-05$102.51/sh−1,252$128,343→ 18,444 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-05-05−2,752→ 2,751 totalExercise: $54.13Exp: 2030-03-01→ Common Stock (2,752 underlying)
Footnotes (4)
- [F1]Effected pursuant to a trading plan adopted on September 12, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $102.01 to $102.94 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $103.23 to $104.06 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]This option was granted on March 1, 2020 and is fully exercisable as of the transaction date.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001769740
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 4:30 PM ET
- Size
- 12.6 KB